Position in PFE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$7,257,803
+$564,790 QoQ
Shares Held
258,469
-3.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Advisory Services Network, LLC holds $159,480,021 across 17 Drug Manufacturers - General names. PFE ranks #7 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
50,669 | $46,603,818 | |
| 2 | ABBV |
AbbVie Inc.
|
118,301 | $25,729,278 | |
| 3 | JNJ |
Johnson & Johnson
|
86,066 | $21,037,966 | |
| 4 | MRK |
Merck & Co., Inc.
|
143,304 | $17,238,032 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
74,137 | $10,332,465 | |
| 6 | AMGN |
Amgen Inc
|
29,101 | $10,239,178 | |
| 7 | PFE |
Pfizer Inc
This page
|
258,469 | $7,257,803 | |
| 8 | NVS |
Novartis AG
|
38,689 | $5,909,741 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,257,803 | 258,469 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,693,013 | 268,796 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,946,491 | 311,872 | Shares | Sole | 2025-11-18 | |
| 2025-06-30 | $8,484,234 | 350,010 | Shares | Sole | 2025-08-19 | |
| 2025-03-31 | $9,102,426 | 359,212 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $9,015,021 | 339,805 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $9,501,083 | 328,303 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,185,911 | 328,303 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $11,178,974 | 402,846 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $12,732,862 | 442,267 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $13,497,865 | 406,930 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $14,236,458 | 388,126 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $13,471,424 | 330,182 | Shares | Sole | 2023-05-17 | |
| 2022-12-31 | $17,275,922 | 337,157 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $15,219,507 | 347,795 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,605,201 | 354,858 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $17,031,654 | 328,987 | Shares | Sole | 2022-05-23 | |
| 2021-12-31 | $24,140,700 | 408,818 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $18,051,723 | 419,710 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $10,515,672 | 268,531 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $10,015,670 | 276,447 | Shares | Sole | 2021-05-24 | |
| 2020-12-31 | $8,923,033 | 242,408 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $8,241,561 | 224,566 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $6,349,492 | 194,174 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $5,985,348 | 183,375 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||